DaVita Inc
Change company Symbol lookup
Select an option...
DVA DaVita Inc
GILD Gilead Sciences Inc
MO Altria Group Inc
CDTI CDTi Advanced Materials Inc
CHFW Consonance-HFW Acquisition Corp
OIIM O2micro International Ltd
CAHC CA Healthcare Acquisition Corp
CAH Cardinal Health Inc
CACC Credit Acceptance Corp
C Citigroup Inc
Go

Health Care : Health Care Providers & Services | Mid Cap Blend
Company profile

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.

Closing Price
$120.25
Day's Change
1.24 (1.04%)
Bid
--
Ask
--
B/A Size
--
Day's High
120.63
Day's Low
118.69
Volume
(Heavy Day)
Volume:
689,688

10-day average volume:
555,917
689,688

DVA's position in the Health Care Providers & Services industry

Industry PeersDVACI

Summary

Company ProfileDaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related...
Cigna Corporation is a health services company that offers medical, dental insurance and related products and services. The Company's segments are Evernorth, U.S. Medical and International Markets...
Go to CI summary
52-Week Change

VS. INDUSTRY
31.97%
28.59%
Market Cap

VS. INDUSTRY
$12.8B
$78.7B
Beta

VS. INDUSTRY
1.3
0.9
Dividend Yield

VS. INDUSTRY
--
1.74%
P/E (TTM, GAAP)

VS. INDUSTRY
18.05x
9.87x
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$11.5B
$163.0B
Profit Margin

VS. INDUSTRY
8.83%
5.20%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
38.64%
23.36%
Revenue Growth (TTM)

VS. INDUSTRY
0.37%
5.79%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.